• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Closing the global vaccine equity gap: equitably distributed manufacturing.

作者信息

Dzau Victor J, Balatbat Celynne A, Offodile Anaeze C

机构信息

Office of the President, US National Academy of Medicine, Washington, DC 20001, USA.

Office of the President, US National Academy of Medicine, Washington, DC 20001, USA.

出版信息

Lancet. 2022 May 21;399(10339):1924-1926. doi: 10.1016/S0140-6736(22)00793-0. Epub 2022 May 6.

DOI:10.1016/S0140-6736(22)00793-0
PMID:35533706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9075857/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/934a/9075857/f3d86e51c6cf/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/934a/9075857/f3d86e51c6cf/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/934a/9075857/f3d86e51c6cf/fx1_lrg.jpg

相似文献

1
Closing the global vaccine equity gap: equitably distributed manufacturing.缩小全球疫苗公平差距：公平分配生产
Lancet. 2022 May 21;399(10339):1924-1926. doi: 10.1016/S0140-6736(22)00793-0. Epub 2022 May 6.
2
Failure to achieve global vaccine equity will have dire consequences.无法实现全球疫苗公平分配将产生严重后果。
BMJ. 2021 Mar 19;372:n712. doi: 10.1136/bmj.n712.
3
COVID-19 vaccine equity and booster doses.新冠疫苗公平性与加强针
Lancet Infect Dis. 2021 Sep;21(9):1193. doi: 10.1016/S1473-3099(21)00486-2. Epub 2021 Aug 13.
4
Canada is no global health leader on COVID-19 vaccine equity.在新冠疫苗公平性方面，加拿大并非全球健康领域的领导者。
Lancet. 2021 May 15;397(10287):1803. doi: 10.1016/S0140-6736(21)00888-6.
5
Learning from past mistakes? The COVID-19 vaccine and the inverse equity hypothesis.从过去的错误中吸取教训？新冠疫苗与反向公平假说。
Eur J Public Health. 2021 Feb 1;31(1):2. doi: 10.1093/eurpub/ckaa243.
6
Regional vaccine production is key to ensuring equity.区域疫苗生产是确保公平的关键。
BMJ. 2021 Sep 28;374:n2354. doi: 10.1136/bmj.n2354.
7
Centring equity over exceptionalism in the global covid-19 response.在全球新冠疫情应对中，将公平置于卓越之上。
BMJ. 2022 Jan 6;376:o20. doi: 10.1136/bmj.o20.
8
Allocating a COVID-19 Vaccine: Balancing National and International Responsibilities.分配 COVID-19 疫苗：平衡国家和国际责任。
Milbank Q. 2021 Jun;99(2):450-466. doi: 10.1111/1468-0009.12494. Epub 2020 Dec 9.
9
Reporting of health equity considerations in vaccine trials for COVID-19: author's reply.关于2019冠状病毒病疫苗试验中健康公平性考量的报告：作者回复
J Clin Epidemiol. 2024 Jul;171:111374. doi: 10.1016/j.jclinepi.2024.111374. Epub 2024 Apr 30.
10
Reporting of health equity considerations in vaccine trials for COVID-19: comment on Kou et al.关于COVID-19疫苗试验中健康公平性考量的报告：对Kou等人文章的评论
J Clin Epidemiol. 2024 Jul;171:111329. doi: 10.1016/j.jclinepi.2024.111329. Epub 2024 Mar 22.

引用本文的文献

1
Decolonizing global health: Africa's pursuit of pharmaceutical sovereignty.非殖民化全球健康：非洲对制药主权的追求。
BMC Health Serv Res. 2025 Aug 1;25(1):1015. doi: 10.1186/s12913-025-13211-9.
2
Association of gross domestic product with equitable access to childhood vaccines in 195 countries: a systematic review and meta-analysis.195个国家国内生产总值与儿童疫苗公平可及性的关联：一项系统评价与荟萃分析
BMJ Glob Health. 2025 Jan 19;10(1):e015693. doi: 10.1136/bmjgh-2024-015693.
3
mRNA vaccines for infectious diseases - advances, challenges and opportunities.

本文引用的文献

1
It is not too late to achieve global covid-19 vaccine equity.实现全球新冠疫苗公平分配还为时不晚。
BMJ. 2022 Mar 24;376:e070650. doi: 10.1136/bmj-2022-070650.
2
COVID-19 vaccine dose sparing: strategies to improve vaccine equity and pandemic preparedness.COVID-19 疫苗剂量节约：提高疫苗公平性和大流行准备的策略。
Lancet Glob Health. 2022 Apr;10(4):e570-e573. doi: 10.1016/S2214-109X(22)00075-4.
3
Vaccine apartheid: global cooperation and equity.疫苗种族隔离：全球合作与公平
传染病的 mRNA 疫苗：进展、挑战与机遇。
Nat Rev Drug Discov. 2024 Nov;23(11):838-861. doi: 10.1038/s41573-024-01042-y. Epub 2024 Oct 4.
4
A brief review on the lessons learned from COVID-19 on drug discovery and research.关于从新冠疫情中汲取的药物发现与研究方面经验教训的简要回顾。
Med Pharm Rep. 2024 Jul;97(3):243-248. doi: 10.15386/mpr-2641. Epub 2024 Jul 30.
5
Health equity requires transformational change: Financial incentives based on worn-out market thinking will not deliver.健康公平需要变革性的改变：基于过时市场思维的经济激励措施无法实现这一目标。
PLOS Glob Public Health. 2024 Apr 25;4(4):e0003147. doi: 10.1371/journal.pgph.0003147. eCollection 2024.
6
Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models.哪些途径通向可及性？六种新冠疫苗创新模式的全球格局。
Global Health. 2024 Mar 26;20(1):25. doi: 10.1186/s12992-024-01017-z.
7
Modeling Supply and Demand Dynamics of Vaccines against Epidemic-Prone Pathogens: Case Study of Ebola Virus Disease.针对易引发流行疾病原体的疫苗供需动态建模：埃博拉病毒病案例研究
Vaccines (Basel). 2023 Dec 25;12(1):24. doi: 10.3390/vaccines12010024.
8
A targeted approach to vaccine hesitancy.一种针对疫苗犹豫的针对性方法。
Oxf Open Immunol. 2023 Oct 28;4(1):iqad007. doi: 10.1093/oxfimm/iqad007. eCollection 2023.
9
Pandemic preparedness requires collaboration between governments, funders and pharma.大流行防范需要政府、资助者和制药公司之间的合作。
Nat Med. 2023 Dec;29(12):2999-3001. doi: 10.1038/s41591-023-02664-2.
10
Africa (COVID-19) Vaccine Technology Transfer: Where Are We?非洲（新冠病毒）疫苗技术转让：我们目前的进展如何？
Life (Basel). 2023 Sep 9;13(9):1886. doi: 10.3390/life13091886.
Lancet. 2022 Apr 16;399(10334):1452-1453. doi: 10.1016/S0140-6736(22)00328-2. Epub 2022 Feb 23.
4
Addressing Vaccine Inequity - Covid-19 Vaccines as a Global Public Good.应对疫苗不平等——将新冠疫苗视为全球公共产品
N Engl J Med. 2022 Mar 24;386(12):1176-1179. doi: 10.1056/NEJMe2202547. Epub 2022 Feb 23.
5
Global vaccine equity demands reparative justice - not charity.全球疫苗公平需要修复性正义——而非慈善。
BMJ Glob Health. 2021 Jun;6(6). doi: 10.1136/bmjgh-2021-006504.
6
From Vaccine Nationalism to Vaccine Equity - Finding a Path Forward.从疫苗民族主义到疫苗公平——探寻前进之路
N Engl J Med. 2021 Apr 8;384(14):1281-1283. doi: 10.1056/NEJMp2103614. Epub 2021 Apr 3.
7
The Equitable Distribution of COVID-19 Therapeutics and Vaccines.新冠治疗药物和疫苗的公平分配
JAMA. 2020 Jun 23;323(24):2462-2463. doi: 10.1001/jama.2020.6641.
8
The complexity and cost of vaccine manufacturing - An overview.疫苗生产的复杂性与成本——概述
Vaccine. 2017 Jul 24;35(33):4064-4071. doi: 10.1016/j.vaccine.2017.06.003. Epub 2017 Jun 21.